Showing results (111-120 of 943) with videos related to
Sort By:
Pageof 95
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2013
In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody developmentMarta Todeschini, Monica Cortinovis, Norberto Perico, et al.Nephron. Clinical Practice|April 24, 2010
Prevention and transplantation in chronic kidney disease: what is achievable in emerging countries? Meeting report: Bamako meeting December 4-6, 2008Veerle P Persy, Giuseppe Remuzzi, Norberto Perico, et al.JNMA; Journal of the Nepal Medical Association|April 18, 2013
Community-based screening for chronic kidney disease, hypertension and diabetes in DharanSanjib Kumar Sharma, Subodh Dhakal, Lekhjung Thapa, et al.Transplantation|February 26, 2019
Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney TransplantationFederica Casiraghi, Marta Todeschini, Nadia Azzollini, et al.Clinical Kidney Journal|May 29, 2015
Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphineLaura Pogliani, Chiara Mameli, Dario Cattaneo, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress reportLuca Antiga, Marina Piccinelli, Giorgio Fasolini, et al.Journal of the American Society of Nephrology : JASN|December 1, 2001
Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantationMarina Noris, Daniela Cugini, Federica Casiraghi, et al.Stem Cells (Dayton, Ohio)|May 24, 2008
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in miceMarina Morigi, Martino Introna, Barbara Imberti, et al.Blood|July 20, 2002
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndromeGiuseppe Remuzzi, Miriam Galbusera, Marina Noris, et al.Frontiers in Immunology|July 3, 2018
Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell ImmunotherapyNorberto Perico, Federica Casiraghi, Marta Todeschini, et al.Pageof 95